Webinar | March 29, 2021

LSX 2021: The Path From Preclinical To And Through Clinical

Presented by:

  • Peter Larson, Vice President, Medical Affairs for Hematology-Oncology
  • Angi Robinson, Vice President, Specialty Areas
  • April Marquick, Cell and Gene Therapy Expert

Originally presented at the 2021 LSX World Congress virtual conference, this webinar series by Premier experts in oncology, rare disease, and cell and gene therapies focuses on development considerations for advanced therapies, highlighting these products’ unique challenges as well as their powerful potential to address a broad array of unmet patient needs.

Both the European and U.S. perspective are addressed with a focus on these three key areas:

  1. Trial Design Considerations
  2. Regulatory Study Start-Up Considerations
  3. Study Execution for Advanced Therapies
VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: